Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01274390 · ClinicalTrials.gov registry record
Impact of Blood Storage Duration on Physiologic Measures
A clinical trial of Cardiac Surgery and Erythrocyte Transfusion, sponsored by Duke University.
- Completed
- Registry status
- 390
- Enrollment target
- 4
- Study locations
NCT01274390 is a study of Cardiac Surgery and Erythrocyte Transfusion that has completed, run by Duke University. The registered enrollment target is 390 participants, below the 725-participant average among 19 other Cardiac Surgery trials with a reported enrollment target (46% lower). The trial reports 4 study locations across 3 states.
The verdict
NCT01274390, a study of Cardiac Surgery and Erythrocyte Transfusion, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 390 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study is an ancillary (add-on) study to the clinical trial entitled Red Cell Storage Duration Study (RECESS), which has clinicaltrials.gov identifier NCT00991341. The RECESS study randomizes cardiac surgery patients to receive either red blood cell units stored for no more than 10 days, or red blood cell units stored for at least 21 days, if they need any red blood cell transfusions during their hospital stay for the surgery. This ancillary study is entitled Impact of Blood Storage Duration on Physiologic Measures: RECESS Ancillary Physiologic Study (RECAP). The hypothesis of the RECAP study is that there will be differences between the two randomized treatment groups in how much the following measurements change, from shortly before a red blood cell transfusion to shortly after a red blood cell transfusion, and from before surgery to 24 hours after surgery: * Oxygen saturation in the hand * Oxygen saturation in the brain * Blood flow in the small blood vessels under the tongue. The RECAP study will also investigate whether changes in the measurements listed above are associated with clinical outcomes, including * The Multi-Organ Dysfunction Score * Death from any cause * Major cardiac events * Major pulmonary events
Conditions Studied
Study Locations (4)
Massachusetts
- Massachusetts General Hospital - Boston
- Brigham and Womens Hospital - Boston
Minnesota
- University of Minnesota - Minneapolis
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 390 participants |
| Start Date | 2011-01 |
| Est. Completion | 2014-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01274390
The ClinicalTrials.gov registry entry for NCT01274390 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 390 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 725-participant average among 19 other Cardiac Surgery trials with a reported enrollment target (46% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cardiac Surgery appearing as the primary indexed condition, and to 0 interventions.
NCT01274390 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Massachusetts, Minnesota, North Carolina.
Frequently Asked Questions
What is clinical trial NCT01274390 about?
NCT01274390 is a clinical study titled "Impact of Blood Storage Duration on Physiologic Measures". This study is an ancillary (add-on) study to the clinical trial entitled Red Cell Storage Duration Study (RECESS), which has clinicaltrials.gov identifier NCT00991341. The RECESS study randomizes cardiac surgery patients to receive either red blood cell units stored for no more than 10 days, or red ...
What is the current status of trial NCT01274390?
This trial is currently completed. The enrollment target is 390 participants. The study started on 2011-01. Estimated completion is 2014-01.
What conditions does trial NCT01274390 study?
This clinical trial studies the following conditions: Cardiac Surgery, Erythrocyte Transfusion.
Who is sponsoring clinical trial NCT01274390?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01274390 being conducted?
This trial has 4 study locations across Massachusetts, Minnesota, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
RECRUITING · NA
-
Oral Methadone in Cardiac Surgery
RECRUITING · Phase 4
-
Cardiopulmonary Bypass Induced Red Blood Cell Lysis
RECRUITING
-
Pilot Study Evaluating the Advantages of Sucrosomial® Iron Post-operative Supplementation vs Standard of Care After Cardiac Surgery
RECRUITING · Early Phase 1
-
Assessing the Burden of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
RECRUITING
-
Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass
RECRUITING · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.